GlassScriptPhysician profile
Janet Kaczor
NPI 1336199538
$2,911.60
in general payments reported to CMS, 2019-2025
18 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.42 · 2020: $49.63 · 2021: $16.40 · 2022: $1,014 · 2023: $616 · 2024: $472 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $941.17 | 2020-2025 | Scopis Ent, Audion Et Dilation System, Clarifix |
| Glaxosmithkline, LLC. | $425.90 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $303.99 | 2022-2025 | Dupixent |
| Optinose US, INC. | $285.73 | 2022-2025 | |
| Genzyme Corporation | $265.16 | 2023-2025 | |
| Csl Behring | $140.65 | 2022-2024 | Hizentra |
| Aerin Medical INC. | $126.41 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $62.21 | 2022-2025 | Tezspire, Airsupra |
| Medtronic, INC. | $54.50 | 2023-2025 | Nuvent, Sinuva |
| Merck Sharp & Dohme LLC | $54.49 | 2023-2025 | Keytruda Qlex, Keytruda |
| Hikma Pharmaceuticals USA | $38.68 | 2024 | Ryaltris |
| Takeda Pharmaceuticals U.S.A., INC. | $37.29 | 2023-2024 | Hyqvia, Cuvitru |
| Jubilant Hollisterstier LLC | $36.07 | 2025 | |
| Intersect Ent, INC. | $34.82 | 2019-2021 | |
| Lucid Diagnostics INC. | $33.01 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $32.57 | 2024 | Perclot |
| Hologic Sales and Service, LLC | $22.12 | 2023 | Coolseal Generator |
| Acclarent, INC | $16.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Kaczor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.